Symptom-centric view

Hypersensitivity

Substances reporting Hypersensitivity disproportionately — ranked by ROR.

Pain Drug ineffective Arthralgia Rheumatoid arthritis Fatigue Joint swelling

showing 10 of 10

Substance ↓	ROR [95% CI]	Reports	Category	Label
nicotinamide Niacinamide	15.4 [13.7–17.5]	291	longevity	new
bimatoprost Latisse · Lumigan	3.5 [3.3–3.7]	853	injectables	new
acetaminophen, guaifenesin, and phenylephrine hydrochloride —	3.2 [3.1–3.3]	4,291	algemeen	new
acetaminophen, chlorpheniramine maleate, phenylephrine hcl —	2.1 [2.0–2.3]	914	algemeen	new
acetaminophen tablet extended release —	4.0 [3.9–4.1]	8,259	algemeen	new
acetaminophen and codeine —	13.0 [12.3–13.7]	1,428	algemeen	new
acetaminophen 500mg —	4.0 [3.9–4.1]	8,265	algemeen	new
acetaminophen —	2.2 [2.2–2.3]	12,572	algemeen	new
abatacept —	8.9 [8.7–9.1]	9,533	algemeen	new
abacavir sulfate —	4.2 [3.9–4.6]	571	algemeen	new

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).